The Organization of Therapy for Aphasia: I. The In-Patient Treatment Center

Advancements in burn treatment, in the last decades, resulted in a reduction of mortality among burn victims. Increased funding and the creation of regional burn treatment facilities focused on comprehensive therapy of severe burns resulted in improvement of treatment outcomes. Effective functioning and usage of resources in burn centers depends on the organization of prehospital care, proper segregation of patients, triage and prompt transfer to a place where highly specialized care is available. Initial care of a burn injury patient includes actions taken by witnesses of the event and by the emergency medical team during transfer to the emergency department. After evaluating and stabilizing the patient, a decision is made whether or not he should be treated at a specialized burn treatment center to which he may be transferred by land or by air. This paper presents burn patient treatment protocols at each of the following stages: at the burn scene, during transportation, initial hospital treatment and criteria for referring the patient to a burn treatment center.

Download Full-text

Initial Treatment of Dialysis Associated Peritonitis: A Controlled Trial of Vancomycin versus Cefazolin

Peritoneal Dialysis International ◽

10.1177/089686089101100108 ◽

1991 ◽

Vol 11 (1) ◽

pp. 31-37 ◽

Cited By ~ 30

Author(s):

Michael J. Flanigan ◽

Victoria s. Lim

Keyword(s):

Peritoneal Dialysis ◽

Hospital Admissions ◽

Controlled Trial ◽

Intraperitoneal Administration ◽

Patient Treatment ◽

Treatment Center ◽

University Of Iowa ◽

Chi Square ◽

Home Dialysis ◽

The University

Objective To determine if intraperitoneal administration of vancomycin (a slowly absorbed antibiotic) im proves the management of dialysis-associated peritonitis over that obtained by using cefazolin, an equally potent, rapidly absorbed antibiotic. Setting A university operated teaching hospital, with patient treatment initiated at home. Patients One hundred thirty-one patients trained to perform peritoneal dialysis (CAPD and CCPD) and followed at the University of Iowa Hospitals and Clinics Home Dialysis Treatment Center. Design Patients were prospectively allocated into groups adding either vancomycin 25 mgm/L, orcefazolin 50 mgm/L to their dialysate when signs or symptoms of peritonitis developed. Treatment results were analysed using chi-square testing. Findings Compared to cefazolin, initial peritonitis therapy with vancomycin improved the peritonitis resolution rate [67% vs 81 %; p=0.008], reduced the incidence of hospital admissions [68% vs 48%; p=0.001], and decreased the risk of superinfection [4% vs 0%; p=0.039]. Conclusion Vancomycin appeared to be superior to cefazolin in the treatment of peritoneal dialysis associated peritonitis.

Download Full-text

Risk Factors for Infection with Different Hepatitis C Virus Genotypes in Southern Brazil

The Scientific World JOURNAL ◽

10.1100/2012/946954 ◽

2012 ◽

Vol 2012 ◽

pp. 1-6 ◽

Cited By ~ 3

Author(s):

Marisa Lúcia Romani Paraboni ◽

Marina Dallagasperina Sbeghen ◽

Fernando Herz Wolff ◽

Leila Beltrami Moreira

Keyword(s):

Risk Factors ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Multinomial Logistic Regression ◽

Patient Treatment ◽

Treatment Center ◽

Southern Brazil ◽

Genotype 1 ◽

Convenience Sample ◽

Genotype 2

Objectives. To investigate the proportion of different genotypes in countryside microregions in southern Brazil, and their association with risk factors.Methods. Cross-sectional study including a convenience sample of patients who tested positive for HCV-RNA and were referred to a regional health center for genotyping, from December 2003 to January 2008. Data were obtained through the National Disease Surveillance Data System, from laboratory registers and from patient charts. Identification of genotypes was carried out using the Restriction Fragment Length Polymorphism “in house” technique. Independent associations with genotypes were evaluated in multinomial logistic regression and prevalence rates of genotypes were estimated with modified Poisson regression.Results. The sample consisted of 441 individuals, years old, 56.5% men. Genotype 1 was observed in 41.5% (95% CI 37.9–48.1) of patients, genotype 2 in 19.3% (95% CI 15.0–23.6), and genotype 3 in 39.2% (95% CI 35.6–43.0). HCV genotype was significantly associated with gender and age. Dental procedures were associated with higher proportion of genotype 2 independently of age, education, and patient treatment center.Conclusions. The hepatitis C virus genotype 1 was the most frequent. Genotype 2 was associated with female gender, age, and dental procedure exposition.

Download Full-text